Enhancing KCC2 function counteracts morphine-induced hyperalgesia

Abstract Morphine-induced hyperalgesia (MIH) is a severe adverse effect accompanying repeated morphine treatment, causing a paradoxical decrease in nociceptive threshold. Previous reports associated MIH with a decreased expression of the Cl− extruder KCC2 in the superficial dorsal horn (SDH) of the...

Full description

Bibliographic Details
Main Authors: Francesco Ferrini, Louis-Etienne Lorenzo, Antoine G. Godin, Miorie Le Quang, Yves De Koninck
Format: Article
Language:English
Published: Nature Portfolio 2017-06-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-017-04209-3
_version_ 1818571669804941312
author Francesco Ferrini
Louis-Etienne Lorenzo
Antoine G. Godin
Miorie Le Quang
Yves De Koninck
author_facet Francesco Ferrini
Louis-Etienne Lorenzo
Antoine G. Godin
Miorie Le Quang
Yves De Koninck
author_sort Francesco Ferrini
collection DOAJ
description Abstract Morphine-induced hyperalgesia (MIH) is a severe adverse effect accompanying repeated morphine treatment, causing a paradoxical decrease in nociceptive threshold. Previous reports associated MIH with a decreased expression of the Cl− extruder KCC2 in the superficial dorsal horn (SDH) of the spinal cord, weakening spinal GABAA/glycine-mediated postsynaptic inhibition. Here, we tested whether the administration of small molecules enhancing KCC2, CLP257 and its pro-drug CLP290, may counteract MIH. MIH was typically expressed within 6–8 days of morphine treatment. Morphine-treated rats exhibited decreased withdrawal threshold to mechanical stimulation and increased vocalizing behavior to subcutaneous injections. Chloride extrusion was impaired in SDH neurons measured as a depolarizing shift in E GABA under Cl− load. Delivering CLP257 to spinal cord slices obtained from morphine-treated rats was sufficient to restore Cl− extrusion capacity in SDH neurons. In vivo co-treatment with morphine and oral CLP290 prevented membrane KCC2 downregulation in SDH neurons. Concurrently, co-treatment with CLP290 significantly mitigated MIH and acute administration of CLP257 in established MIH restored normal nociceptive behavior. Our data indicate that enhancing KCC2 activity is a viable therapeutic approach for counteracting MIH. Chloride extrusion enhancers may represent an effective co-adjuvant therapy to improve morphine analgesia by preventing and reversing MIH.
first_indexed 2024-12-14T14:59:03Z
format Article
id doaj.art-0eca9d636d3343e999ceb6e781d6238c
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-14T14:59:03Z
publishDate 2017-06-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-0eca9d636d3343e999ceb6e781d6238c2022-12-21T22:56:53ZengNature PortfolioScientific Reports2045-23222017-06-01711810.1038/s41598-017-04209-3Enhancing KCC2 function counteracts morphine-induced hyperalgesiaFrancesco Ferrini0Louis-Etienne Lorenzo1Antoine G. Godin2Miorie Le Quang3Yves De Koninck4Department of Veterinary Sciences, University of TurinCERVO Brain Research Centre, Institut universitaire en santé mentale de QuébecCERVO Brain Research Centre, Institut universitaire en santé mentale de QuébecCERVO Brain Research Centre, Institut universitaire en santé mentale de QuébecCERVO Brain Research Centre, Institut universitaire en santé mentale de QuébecAbstract Morphine-induced hyperalgesia (MIH) is a severe adverse effect accompanying repeated morphine treatment, causing a paradoxical decrease in nociceptive threshold. Previous reports associated MIH with a decreased expression of the Cl− extruder KCC2 in the superficial dorsal horn (SDH) of the spinal cord, weakening spinal GABAA/glycine-mediated postsynaptic inhibition. Here, we tested whether the administration of small molecules enhancing KCC2, CLP257 and its pro-drug CLP290, may counteract MIH. MIH was typically expressed within 6–8 days of morphine treatment. Morphine-treated rats exhibited decreased withdrawal threshold to mechanical stimulation and increased vocalizing behavior to subcutaneous injections. Chloride extrusion was impaired in SDH neurons measured as a depolarizing shift in E GABA under Cl− load. Delivering CLP257 to spinal cord slices obtained from morphine-treated rats was sufficient to restore Cl− extrusion capacity in SDH neurons. In vivo co-treatment with morphine and oral CLP290 prevented membrane KCC2 downregulation in SDH neurons. Concurrently, co-treatment with CLP290 significantly mitigated MIH and acute administration of CLP257 in established MIH restored normal nociceptive behavior. Our data indicate that enhancing KCC2 activity is a viable therapeutic approach for counteracting MIH. Chloride extrusion enhancers may represent an effective co-adjuvant therapy to improve morphine analgesia by preventing and reversing MIH.https://doi.org/10.1038/s41598-017-04209-3
spellingShingle Francesco Ferrini
Louis-Etienne Lorenzo
Antoine G. Godin
Miorie Le Quang
Yves De Koninck
Enhancing KCC2 function counteracts morphine-induced hyperalgesia
Scientific Reports
title Enhancing KCC2 function counteracts morphine-induced hyperalgesia
title_full Enhancing KCC2 function counteracts morphine-induced hyperalgesia
title_fullStr Enhancing KCC2 function counteracts morphine-induced hyperalgesia
title_full_unstemmed Enhancing KCC2 function counteracts morphine-induced hyperalgesia
title_short Enhancing KCC2 function counteracts morphine-induced hyperalgesia
title_sort enhancing kcc2 function counteracts morphine induced hyperalgesia
url https://doi.org/10.1038/s41598-017-04209-3
work_keys_str_mv AT francescoferrini enhancingkcc2functioncounteractsmorphineinducedhyperalgesia
AT louisetiennelorenzo enhancingkcc2functioncounteractsmorphineinducedhyperalgesia
AT antoineggodin enhancingkcc2functioncounteractsmorphineinducedhyperalgesia
AT miorielequang enhancingkcc2functioncounteractsmorphineinducedhyperalgesia
AT yvesdekoninck enhancingkcc2functioncounteractsmorphineinducedhyperalgesia